Financial statements 4Cell Therapies
Cash flow statement of 4Cell Therapies
Company age:
Age:
8 y. 2 m. 21 d.
Share capital:
Share capital:
1 101 950 PLN
Cash inflows of 4CELL THERAPIES
|
Year
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -3 140 889,66 | -3 374 186,02 | -2 049 465,91 | -2 487 900,45 | -2 684 159,95 | -4 288 206,37 |
| Net cash flow from investing activities | -80 316,68 | -31 668,60 | -15 611,54 | -22 052,67 | -1 028 629,40 | -1 161 714,00 |
| Net cash flow from financial activities | 3 328 425,18 | 3 352 216,86 | 4 433 648,05 | 7 238 367,41 | 0,00 | 2 494 563,50 |
| Total net cash flow | 107 218,84 | -53 637,76 | 2 368 570,60 | 4 728 414,29 | -3 712 789,35 | -2 955 356,87 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.